Pulse Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Pulse Biosciences, Inc. (PLSE) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.22 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-19
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.22M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.23M.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.23M.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.23M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $2.22M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.23M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.23M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.23M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.15M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.98M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.98M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $1.98M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.91M 10-K · filed 2024-03-28 |
| 2023-09-30 | $1.91M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.91M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.91M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.84M 10-K · filed 2023-03-31 |
| 2022-09-30 | $1.84M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.84M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.84M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.81M 10-K · filed 2022-03-31 |
| 2021-09-30 | $1.81M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.81M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.81M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.64M 10-K · filed 2021-03-12 |
| 2020-09-30 | $1.64M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.64M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $986.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $647.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |